IPO - SELLAS Life Sciences Group, Inc.

Form Type: 424B5

Filing Date: 2025-01-29

Corporate Action: Ipo

Type: New

Accession Number: 000110465925007097

Filing Summary: SELLAS Life Sciences Group, Inc. is offering a total of 8,200,000 shares of its common stock along with pre-funded warrants to purchase up to 11,485,040 shares of common stock, and warrants to purchase up to 19,685,040 shares of common stock. The offering will enable investors to buy shares and warrants bundled together; however, each will be issued separately and can be exercised immediately after issuance. The pricing includes a public offering price of $1.27 per share including an accompanying warrant, and $1.2699 per pre-funded warrant with an accompanying warrant. Notably, pre-funded warrants are offered to avoid breaching limits on ownership percentages for investors. The securities are expected to be delivered on January 29, 2025, raising an estimated net proceed of approximately $23.1 million which will be used for funding ongoing operations and clinical developments. Placement agents for this offering include A.G.P./Alliance Global Partners and Maxim Group LLC.

Document Link: View Document